Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | prolyl oligopeptidase family protein | 0.21 | 0.5551 | 1 |
Schistosoma mansoni | subfamily S9B unassigned peptidase (S09 family) | 0.21 | 0.5551 | 0.5478 |
Mycobacterium tuberculosis | Probable protease II PtrBa [first part] (oligopeptidase B) | 0.0343 | 0.0085 | 1 |
Plasmodium falciparum | dipeptidyl aminopeptidase 1 | 0.3531 | 1 | 1 |
Echinococcus granulosus | prolyl endopeptidase | 0.0546 | 0.0717 | 0.1033 |
Plasmodium vivax | dipeptidyl aminopeptidase 1, putative | 0.3531 | 1 | 1 |
Echinococcus granulosus | Dipeptidyl peptidase 9 | 0.0733 | 0.1298 | 0.2109 |
Mycobacterium ulcerans | protease II (oligopeptidase B), PtrB | 0.0316 | 0 | 0.5 |
Plasmodium vivax | dipeptidyl aminopeptidase 2, putative | 0.3531 | 1 | 1 |
Toxoplasma gondii | dipeptidyl peptidase iv (dpp iv) n-terminal region domain-containing protein | 0.0733 | 0.1298 | 0.0625 |
Toxoplasma gondii | preprocathepsin c precursor, putative | 0.3531 | 1 | 1 |
Toxoplasma gondii | cathepsin CPC1 | 0.3531 | 1 | 1 |
Mycobacterium leprae | PROBABLE PROTEASE II PTRBB (OLIGOPEPTIDASE B) | 0.0316 | 0 | 0.5 |
Trypanosoma cruzi | serine peptidase, Clan SC, Family S9B | 0.0733 | 0.1298 | 1 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0546 | 0.0717 | 0.0566 |
Plasmodium falciparum | dipeptidyl aminopeptidase 2 | 0.3531 | 1 | 1 |
Echinococcus multilocularis | prolyl endopeptidase | 0.0546 | 0.0717 | 0.1033 |
Trypanosoma brucei | prolyl endopeptidase | 0.0546 | 0.0717 | 0.5528 |
Schistosoma mansoni | dipeptidyl-peptidase I (C01 family) | 0.3531 | 1 | 1 |
Schistosoma mansoni | prolyl oligopeptidase (S09 family) | 0.0546 | 0.0717 | 0.0566 |
Trypanosoma brucei | serine peptidase, Clan SC, Family S9B | 0.0733 | 0.1298 | 1 |
Loa Loa (eye worm) | prolyl oligopeptidase | 0.21 | 0.5551 | 1 |
Echinococcus multilocularis | dipeptidyl aminopeptidaseprotein | 0.21 | 0.5551 | 1 |
Echinococcus multilocularis | Dipeptidyl peptidase 9 | 0.0733 | 0.1298 | 0.2109 |
Trypanosoma brucei | Dipeptidyl-peptidase 8-like, putative | 0.0733 | 0.1298 | 1 |
Onchocerca volvulus | Dipeptidyl peptidase family member 1 homolog | 0.21 | 0.5551 | 1 |
Leishmania major | dipeptidyl-peptidase 8-like serine peptidase, putative,serine peptidase, Clan SC, Family S9B | 0.0733 | 0.1298 | 1 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0546 | 0.0717 | 0.0107 |
Brugia malayi | prolyl oligopeptidase family protein | 0.0733 | 0.1298 | 0.1295 |
Toxoplasma gondii | cathepsin CPC2 | 0.1342 | 0.3193 | 0.2667 |
Trypanosoma cruzi | dipeptidyl-peptidase 8-like serine peptidase | 0.0733 | 0.1298 | 1 |
Echinococcus granulosus | dipeptidyl aminopeptidaseprotein | 0.21 | 0.5551 | 1 |
Leishmania major | prolyl oligopeptidase, putative,serine peptidase clan SC, family S9A, putative | 0.0546 | 0.0717 | 0.5528 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin B-like cysteine peptidase | 0.2193 | 0.5838 | 0.5 |
Trypanosoma cruzi | prolyl endopeptidase | 0.0546 | 0.0717 | 0.5528 |
Schistosoma mansoni | dipeptidyl-peptidase 9 (S09 family) | 0.0733 | 0.1298 | 0.1156 |
Loa Loa (eye worm) | hypothetical protein | 0.0546 | 0.0717 | 0.0107 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 100 uM | In vitro inhibitory activity against human prostaglandin G/H synthase 2 | ChEMBL. | 9171872 |
IC50 (binding) | > 100 uM | In vitro inhibitory activity against human prostaglandin G/H synthase 1 | ChEMBL. | 9171872 |
IC50 (binding) | > 100 uM | In vitro inhibitory activity against human prostaglandin G/H synthase 2 | ChEMBL. | 9171872 |
IC50 (binding) | > 100 uM | In vitro inhibitory activity against human prostaglandin G/H synthase 1 | ChEMBL. | 9171872 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.